Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Clasificación en acciones #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Precio por acción
$0.16240909
Última sincronización: 2025-03-04
Capitalización bursátil
$35.68M
Cambio (1 día)
0.27%
Cambio (1 año)
0.00%
País
CN
Comercio Dali Pharmaceuticalco.,Ltd (603963)

Categoría

Ratio P/S de Dali Pharmaceuticalco.,Ltd (603963)
Ratio P/S al August 2026 TTM: 2.97
Según los informes financieros más recientes y el precio de las acciones de Dali Pharmaceuticalco.,Ltd, el ratio P/S actual (TTM) es 2.97. Al final de 2022, el ratio P/S era 21.68.
Historial del ratio P/S de Dali Pharmaceuticalco.,Ltd desde 2012 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 2.97 -90.20%
2023 30.30 39.75%
2022 21.68 91.44%
2021 11.32 41.15%
2020 8.02 23.66%
2019 6.49 60.68%
2018 4.04 -47.25%
2017 7.66 55.55%
2016 4.92 16.41%
2015 4.23 57.93%
2014 2.68 -12.09%
2013 3.04 -4.22%
2012 3.18 0.00%
Ratio P/S de empresas similares o competidoras